Equities

BioCryst Pharmaceuticals Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

BioCryst Pharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)6.55
  • Today's Change0.25 / 3.97%
  • Shares traded5.29m
  • 1 Year change-24.10%
  • Beta0.7963
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Tuesday, BioCryst Pharmaceuticals Inc (BCRX:NSQ) closed at 6.55, 9.17% above its 52-week low of 6.00, set on Oct 14, 2025.
52-week range
Today
6.00Oct 14 202511.31Jun 04 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open6.31
High6.64
Low6.30
Bid6.40
Offer6.63
Previous close6.30
Average volume3.98m
Shares outstanding248.04m
Free float244.75m
P/E (TTM)--
Market cap1.56bn USD
EPS (TTM)-0.0473
USD
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.